Amgen 2007 Annual Report Download - page 9

Board of Directors
Leadership
Amgen Inc. Corporate Office
One Amgen Center Drive
Thousand Oaks, California 91320-1799
[phone]
Amgen 2007 Annual Report Summary and SEC Form 10-K
Additional copies of the Company’s Form 10-K for the year ended December 31,
2007, filed with the Securities and Exchange Commission, are available without
charge, upon written request to Investor Relations, Amgen, One Amgen Center
Drive, Thousand Oaks, California 91320-1799, by calling (800) 84-AMGEN
or by accessing the Company’s website at www.amgen.com.
Transfer Agent and Registrar
American Stock Transfer & Trust Company
59 Maiden Lane
New York, New York 10038
Stockholder Inquiries
Inquiries related to stock transfers or lost certificates should be directed to
American Stock Transfer & Trust Company, [phone] or [phone]
(www.amstock.com). General information regarding the Company and recent
news releases can be obtained by contacting Amgen’s automated stockholder
information line at (800) 84-AMGEN or by accessing the Company’s website
at www.amgen.com.
Independent Registered Public Accounting Firm
Ernst & Young LLP
Los Angeles, California
Annual Meeting
The Annual Meeting will be held on Wednesday, May 7, 2008, at 2 p.m. at the
Four Seasons Hotel, Two Dole Drive, Westlake Village, California 91362.
Price Range of Common Stock
The Company’s common stock trades on the NASDAQ Stock Market under the
symbol AMGN. No cash dividends have been paid on the common stock to date,
and we currently do not intend to pay any dividends.
The following table sets forth, for the fiscal periods indicated, the range of high
and low closing sales prices of the common stock as quoted on the NASDAQ
Stock Market for the years 2007 and 2006:
Stockholder Information
Trademarks Listed in This Report
Amgen, Aranesp®
, Enbrel® , EPOGEN® , Kepivance® , Kineret® , Mimpara® , Neulasta® , NEUPOGEN® , Nplate™ , Sensipar® , and Vectibix™ are trademarks of Amgen Inc. or its wholly owned subsidiaries.
Hotlines
Customer Service (800) 28-AMGEN Investor Materials (800) 84-AMGEN Jobline [phone] Medical Information (800) 77-AMGEN Reimbursement [phone]
Design by Saputo Design, Inc. Select photographs by David Zaitz Photography Photographs of Kevin Sharer and Dennis Fenton ©Jamey Stillings Photography
David Baltimore
President Emeritus and
Robert Andrews Millikan
Professor of Biology, California
Institute of Technology
Frank J. Biondi, Jr.
Senior Managing Director,
WaterView Advisors LLC
Jerry D. Choate
Retired Chairman and CEO,
The Allstate Corporation
Vance D. Coffman
Retired Chairman
of the Board and CEO,
Lockheed Martin Corporation
Frederick W. Gluck
Former Managing Director,
McKinsey & Company, Inc.
Frank C. Herringer
Chairman and Retired CEO,
Transamerica Corporation
Gilbert S. Omenn
Professor of Internal Medicine,
Human Genetics & Public
Health and Director of the
Center for Computational
Medicine and Biology,
University of Michigan,
and former CEO,
University of Michigan
Health System
Judith C. Pelham
President Emeritus,
Trinity Health
ADM. J. Paul Reason,
USN (Retired)
Former Vice Chairman
and President, Metro
Machine Corporation
Leonard D. Schaeffer
Chairman,
Surgical Care Affiliates
Kevin W. Sharer
Chairman of the Board,
CEO and President,
Amgen Inc.
Madhavan Balachandran
Senior Vice President,
Manufacturing
David W. Beier
Senior Vice President,
Global Government and
Corporate Affairs
Fabrizio Bonanni
Executive Vice President,
Operations
Robert A. Bradway
Executive Vice President
and Chief Financial Officer
James M. Daly
Senior Vice President,
North America Commercial
Operations
Willard H. Dere
Senior Vice President and
International Chief Medical
Officer
Paul R. Eisenberg
Senior Vice President,
Global Regulatory Affairs
and Safety
Thomas J. Flanagan
Senior Vice President and
Chief Information Officer
Sean E. Harper
Senior Vice President, Global
Development, and Corporate
Chief Medical Officer
Rolf K. Hoffmann
Senior Vice President,
Amgen International
Commercial Operations
David L. Lacey
Senior Vice President,
Discovery Research
Brian M. McNamee
Senior Vice President,
Human Resources
Joseph P. Miletich
Senior Vice President,
Research and Development
George J. Morrow
Executive Vice President,
Global Commercial Operations
Roger M. Perlmutter
Executive Vice President,
Research and Development
David J. Scott
Senior Vice President,
General Counsel and Secretary
Kevin W. Sharer
Chairman of the Board,
CEO and President
Geoffrey F. Slaff
Senior Vice President,
Quality
7
2007 2006
High Low High Low
4th Quarter $ 58.17 $ 4 6 . 4 4 $ 76.50 $ 68.31
3rd Quarter 57.16 49.01 72.14 63.92
2nd Quarter 65.10 53.68 72.86 63.94
1st Quarter 75.85 55.72 80.36 71.01